Positive and negative regulation of type II TGF‐β receptor signal transduction by autophosphorylation on multiple serine residues

The type II transforming growth factor‐β (TGF‐β) receptor Ser/Thr kinase (TβRII) is responsible for the initiation of multiple TGF‐β signaling pathways, and loss of its function is associated with many types of human cancer. Here we show that TβRII kinase is regulated intricately by autophosphorylation on at least three serine residues. Ser213, in the membrane‐proximal segment outside the kinase domain, undergoes intra‐molecular autophosphorylation which is essential for the activation of TβRII kinase activity, activation of TβRI and TGF‐β‐induced growth inhibition. In contrast, phosphorylation of Ser409 and Ser416, located in a segment corresponding to the substrate recognition T‐loop region in a three‐dimensional structural model of protein kinases, is enhanced by receptor dimerization and can occur via an inter‐molecular mechanism. Phosphorylation of Ser409 is essential for TβRII kinase signaling, while phosphorylation of Ser416 inhibits receptor function. Mutation of Ser416 to alanine results in a hyperactive receptor that is better able than wild‐type to induce TβRI activation and subsequent cell cycle arrest. Since on a single receptor either Ser409 or Ser416, but not both simultaneously, can become autophosphorylated, our results show that TβRII phosphorylation is regulated intricately and affects TGF‐β receptor signal transduction both positively and negatively.

[1]  H. Lodish,et al.  The types II and III transforming growth factor-beta receptors form homo-oligomers , 1994, The Journal of cell biology.

[2]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[3]  K. Luo,et al.  Cyanogen bromide cleavage and proteolytic peptide mapping of proteins immobilized to membranes. , 1991, Methods in enzymology.

[4]  Elizabeth J. Goldsmith,et al.  Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution , 1994, Nature.

[5]  D. Riddle,et al.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. , 1994, The Journal of biological chemistry.

[6]  J. Massagué,et al.  Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells , 1994, Molecular and Cellular Biology.

[7]  L. Mathews,et al.  Expression cloning of an activin receptor, a predicted transmembrane serine kinase , 1991, Cell.

[8]  J. Massagué,et al.  Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex , 1995, Molecular and cellular biology.

[9]  T. Pawson,et al.  The PTB domain: a new protein module implicated in signal transduction. , 1995, Trends in biochemical sciences.

[10]  T. Hunter,et al.  Mutation of Tyr697, a GRB2‐binding site, and Tyr721, a PI 3‐kinase binding site, abrogates signal transduction by the murine CSF‐1 receptor expressed in Rat‐2 fibroblasts. , 1993, The EMBO journal.

[11]  D. Riddle,et al.  The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development , 1993, Nature.

[12]  C. Chan,et al.  The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation. , 1994, The Journal of biological chemistry.

[13]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[14]  V. Baldin,et al.  Effects of TGF‐β1 (transforming growth factor‐β1) on the cell cycle regulation of human breast adenocarcinoma (MCF‐7) cells , 1995 .

[15]  Jonathan A. Cooper,et al.  Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. , 1992, The EMBO journal.

[16]  J. Zheng,et al.  Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.

[17]  K. Miyazono,et al.  Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.

[18]  L. Mathews,et al.  Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. , 1992, Science.

[19]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[20]  H. Lodish,et al.  Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Tony Pawson,et al.  Structure and function of SH2 domains , 1994, Journal of Cell Science.

[22]  H. Lodish,et al.  Signaling by chimeric erythropoietin‐TGF‐beta receptors: homodimerization of the cytoplasmic domain of the type I TGF‐beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. , 1996, The EMBO journal.

[23]  H. Lodish,et al.  A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma , 1996, Molecular and cellular biology.

[24]  K. Miyazono,et al.  Cloning and characterization of a human type II receptor for bone morphogenetic proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Weinberg,et al.  Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Kurten,et al.  Association of Epidermal Growth Factor Receptors with Coated Pit Adaptins via a Tyrosine Phosphorylation-regulated Mechanism (*) , 1995, The Journal of Biological Chemistry.

[27]  J. Willson,et al.  Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells , 1994 .

[28]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[29]  H. Lodish,et al.  The specificity of the transforming growth factor beta receptor kinases determined by a spatially addressable peptide library. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[31]  J. Massagué,et al.  Loss of receptors for transforming growth factor beta in human T-cell malignancies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Massagué,et al.  Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.

[33]  P. Allen,et al.  Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.

[34]  M. Kamps Determination of phosphoamino acid composition by acid hydrolysis of protein blotted to Immobilon. , 1991, Methods in enzymology.

[35]  M. Sporn,et al.  The Transforming Growth Factor-βs , 1991 .

[36]  K. Miyazono,et al.  Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.

[37]  H. Lodish,et al.  GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor and Activin-A (*) , 1995, The Journal of Biological Chemistry.

[38]  김성진 Transforming Growth Factor-βs , 1996 .

[39]  J. Massagué,et al.  Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.

[40]  J. Massagué,et al.  Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors , 1992, Cell.

[41]  R. Derynck,et al.  Homomeric interactions between type II transforming growth factor-beta receptors. , 1994, The Journal of biological chemistry.

[42]  G. Nolan,et al.  Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. L. Gustafson,et al.  A transforming growth factor beta type I receptor that signals to activate gene expression. , 1994, Science.

[44]  S. Hubbard,et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.

[45]  M. Sporn,et al.  Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. , 1994, Proceedings of the National Academy of Sciences of the United States of America.